# Crossover Study With MultiHance vs a Comparator for Peripheral MRA

> **NCT00408083** · PHASE3 · COMPLETED · sponsor: **Bracco Diagnostics, Inc** · enrollment: 100 (estimated)

## Conditions studied

- Peripheral Vascular Disease

## Interventions

- **DRUG:** MultiHance
- **DRUG:** Magnevist

## Key facts

- **NCT ID:** NCT00408083
- **Lead sponsor:** Bracco Diagnostics, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-11
- **Final completion:** 2008-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2009-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00408083

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00408083, "Crossover Study With MultiHance vs a Comparator for Peripheral MRA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00408083. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*